Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma.
Massaguer
Sara
S
Sánchez
Marcelo
M
Castel
Teresa
T
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis / Q000473:pathology; D008477:Mediastinal Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D011994:Recombinant Proteins; D012507:Sarcoidosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins